Study Investigates Antioxidants and Brain Fog in Diabetes

Understanding Diabetes and Its Effects

Researchers from Scotland have utilized a mouse model to explore the potential of antioxidants in alleviating brain fog associated with diabetes. Typically, blood sugar levels increase after eating, prompting the pancreas to release insulin. This hormone signals cells to utilize sugar for energy or store it as fat. Once blood glucose levels are adequately lowered, insulin production by the pancreas ceases.

Diabetes is a chronic condition characterized by the body’s inability to effectively regulate blood sugar levels. Persistently high blood sugar can lead to damage to blood vessels, organs, and nerves over time.

Managing Diabetes

Effective diabetes management necessitates lifestyle adjustments, diligent monitoring of blood glucose levels, and daily medications to control blood sugar. However, insulin therapy can often lead to episodes of low blood sugar, known as hypoglycaemia. Recurring or prolonged hypoglycaemia has been linked to cognitive decline, commonly referred to as ‘brain fog.’ Individuals with type 1 diabetes, who rely on insulin, may face long-term challenges with learning and memory, contributing to the phenomenon known as diabetes brain fog.

Building Upon Previous Research

A recent study led by Dr. Alison McNeilly builds upon earlier findings that highlighted elevated free radical levels in the brains of individuals experiencing recurrent low blood sugar. In this study, conducted at the University of Dundee in Scotland, Dr. McNeilly and her team induced type 1 diabetes in eight male mice using insulin implants. The mice were divided into three distinct groups:

1. Three mice with type 1 diabetes and recurring hypoglycaemia.
2. Three mice with type 1 diabetes and recurring hypoglycaemia who received the antioxidant sulforaphane.
3. Three mice with type 1 diabetes serving as the control group.

The study revealed that the mice treated with sulforaphane outperformed their counterparts in tasks related to novel object recognition. Additionally, these mice exhibited lower levels of free radicals in the brain.

Need for Further Research

While further investigation into the activation of antioxidant pathways is warranted, this study suggests that enhancing the body’s antioxidant levels may benefit the cognitive health of diabetic patients suffering from recurrent hypoglycaemia. Patients experiencing ‘brain fog’ should consult their healthcare provider for guidance.

Reference

McNeilly, A. et al. (2018) Nrf2 mediated protection against hypoglycaemia induced cognitive deficits in type 1 diabetes. Presented at Society for Endocrinology 2018, Glasgow, UK. Endocrine Abstracts 59 P108. DOI: 10.1530/endoabs.59.P108.
Image by Engin Akyurt from Pixabay.